At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 39 enrolled
Drug / intervention
Acetylcysteine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient
In Brief
A Phase 4 clinical trial evaluating continuous high frequency oscillator (CHFO), Acetylcysteine, and 1 other intervention for Atelectasis. Completed, enrolled 39 participants.
Detailed Summary
The purpose of this study is to evaluate whether a therapy that uses a machine called a continuous high frequency oscillator (CHFO) is more successful at removing mucus than medications that thin out the mucus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtelectasis
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
Primary CompletionMay 2012
Study CompletionJul 2012
First PostedJun 2014
TodayJul 2026
First PostedJun 20, 2014
Enrollment StartDec 1, 2010
Primary CompletionMay 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 12.0 years ago
Interventions
continuous high frequency oscillator (CHFO)device
Acetylcysteinedrug
dornase alfadrug